To access the clinical value of combined18F-FDG and 18F-DCFPyL PET/CT in postoperative recurrent or metastasis renal cell carcinoma

Conclusions: According to our results, 18F-DCFPyL PET/CT is better than 18F-FDG PET/CT in detecting bone metastasis and distinguishing benign and malignant lesions, but in the diagnosis of lymph node metastasis, FDG has advantages over PSMA. Our preliminary experience suggests that 18F-DCFPyL PET/CT may play a complementary role to 18F-FDG in detecting postoperative recurrent and metastasis of ccRCC. Acknowledgement: Finally, I would like to express my sincere gratitude to the anonymous reviewers for their significant contributions to the publication and improvement of my thesis.

Source: Journal of Nuclear Medicine - May 14, 2020 Category: Nuclear Medicine Authors: Wang, G., Liu, Y., Ning, J., Lin, M., Wu, Y., Xu, B., Gao, J. Tags: PSMA and DCFPyL Source Type: research